Alzheimer's disease (AD) is the most common cause of dementia. It is characterized by
cognitive decline and progressive memory loss. The aim of this review was to update the …

Neurodegenerative diseases (NDs) have become a significant threat to an aging human
society. Numerous studies have been conducted in the past decades to clarify their …

Immune recognition of excessive neurotoxins by microglia is a trigger for the onset of
neuroinflammation in the brain, leading to neurodegeneration in Alzheimer's disease (AD) …

Objective. Many stroke victims have severe swallowing problems. Previous neuroimaging
studies have found that several brain regions scattered in the frontal, temporal, and parietal …

Abnormal cerebral accumulation of amyloid-beta peptide (Aβ) is a major hallmark of
Alzheimer's disease. Non-invasive monitoring of Aβ deposits enables assessing the disease …

Alzheimer's disease (AD) is an incurable, age-related neurological disorder, the most
common form of dementia. Considering that AD is a multifactorial complex disease …

Alzheimer's disease (AD) is a central neurodegenerative disorder characterized by
behavioral disturbance and progressive cognitive impairment, and it is common in pre …

Amyloid-β oligomers (AβOs) was the core-biomarker of Alzheimer's disease (AD), and the
detection of AβOs is very important for the early diagnosis of AD. However, existing tests for …

Noninvasive imaging of amyloid-β (Aβ) species in vivo is important for the early diagnosis of
Alzheimer's disease (AD). In this paper, we report a near-infrared (NIR) fluorescence (FL) …

Alzheimer's disease is the most common cause of dementia and a leading cause of mortality
in the elderly population. Diagnosis of Alzheimer's disease has traditionally relied on …